These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1724376)

  • 1. Peroxisomal disorders.
    Moser HW; Bergin A; Cornblath D
    Biochem Cell Biol; 1991 Jul; 69(7):463-74. PubMed ID: 1724376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of branched chain fatty acids in peroxisomal disorders.
    Singh H; Usher S; Johnson D; Poulos A
    J Inherit Metab Dis; 1990; 13(3):387-9. PubMed ID: 1700192
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders.
    Slawecki ML; Dodt G; Steinberg S; Moser AB; Moser HW; Gould SJ
    J Cell Sci; 1995 May; 108 ( Pt 5)():1817-29. PubMed ID: 7544797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisomal disorders. Neurodevelopmental and biochemical aspects.
    Brown FR; Voigt R; Singh AK; Singh I
    Am J Dis Child; 1993 Jun; 147(6):617-26. PubMed ID: 7685145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisomal disorders: clinical commentary and future prospects.
    Wilson GN; Holmes RD; Hajra AK
    Am J Med Genet; 1988 Jul; 30(3):771-92. PubMed ID: 2461077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyceryl ethers in peroxisomal disease.
    Poulos A; Bankier A; Beckman K; Johnson D; Robertson EF; Sharp P; Sheffield L; Singh H; Usher S; Wise G
    Clin Genet; 1991 Jan; 39(1):13-25. PubMed ID: 1705185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical biochemical and genetic aspects of peroxisome-deficient disorders].
    Suzuki Y
    No To Hattatsu; 1992 Mar; 24(2):194-7. PubMed ID: 1373633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical abnormalities in rhizomelic chondrodysplasia punctata.
    Hoefler G; Hoefler S; Watkins PA; Chen WW; Moser A; Baldwin V; McGillivary B; Charrow J; Friedman JM; Rutledge L
    J Pediatr; 1988 May; 112(5):726-33. PubMed ID: 2452243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.
    Wanders RJ; van Roermund CW; van Wijland MJ; Heikoop J; Schutgens RB; Schram AW; Tager JM; van den Bosch H; Poll-Thé BT; Saudubray JM
    Clin Chim Acta; 1987 Jul; 166(2-3):255-63. PubMed ID: 2441904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches in peroxisomal disorders.
    Moser HW
    Dev Neurosci; 1987; 9(1):1-18. PubMed ID: 3297624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very long-chain fatty acids in peroxisomal disease.
    Poulos A; Beckman K; Johnson DW; Paton BC; Robinson BS; Sharp P; Usher S; Singh H
    Adv Exp Med Biol; 1992; 318():331-40. PubMed ID: 1378993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisomal disorders. A review of a recently recognized group of clinical entities.
    Talwar D; Swaiman KF
    Clin Pediatr (Phila); 1987 Oct; 26(10):497-504. PubMed ID: 2443295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of a novel arachidonic acid metabolite in peroxisomes.
    Gordon JA; Heller SK; Rhead WJ; Watkins PA; Spector AA
    Prostaglandins Leukot Essent Fatty Acids; 1995; 52(2-3):77-81. PubMed ID: 7540307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of straight chain and branched chain fatty acid oxidation in skin fibroblasts from patients with peroxisomal disorders.
    Singh H; Usher S; Johnson D; Poulos A
    J Lipid Res; 1990 Feb; 31(2):217-25. PubMed ID: 1691260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisomal disorders in neurology.
    Wanders RJ; Heymans HS; Schutgens RB; Barth PG; van den Bosch H; Tager JM
    J Neurol Sci; 1988 Dec; 88(1-3):1-39. PubMed ID: 3066850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
    Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM
    Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisomal disorders: clinical characterization.
    Monnens L; Heymans H
    J Inherit Metab Dis; 1987; 10 Suppl 1():23-32. PubMed ID: 2446046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisomal integral membrane proteins in livers of patients with Zellweger syndrome, infantile Refsum's disease and X-linked adrenoleukodystrophy.
    Small GM; Santos MJ; Imanaka T; Poulos A; Danks DM; Moser HW; Lazarow PB
    J Inherit Metab Dis; 1988; 11(4):358-71. PubMed ID: 2468817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ether lipid synthesis and its deficiency in peroxisomal disorders.
    van den Bosch H; Schrakamp G; Hardeman D; Zomer AW; Wanders RJ; Schutgens RB
    Biochimie; 1993; 75(3-4):183-9. PubMed ID: 8507680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peroxisomes and neurologic diseases].
    Sereni C; Paturneau-Jouas M
    Rev Neurol (Paris); 1989; 145(5):341-9. PubMed ID: 2472665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.